SCHEMBL7147700

SCHEMBL7147700

CC1CN[C@@H](C=S)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4959119 0.75 — —
SCHEMBL18526310 0.75 — —
SCHEMBL4423704 0.75 — —
SCHEMBL4956679 0.75 — —
SCHEMBL13980015 0.75 — —
SCHEMBL25111573 0.75 — —
SCHEMBL14649310 0.75 — —
SCHEMBL7133444 0.75 — —
SCHEMBL19987628 0.71 — —
SCHEMBL27303333 0.70 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1361212-A1 Peptide derivatives as antithrombotic agents AstraZeneca AB (SE) 2003-11-12 — — EP claimed
US-5726159-A PEPTIDE THROMBIN INHIBITORS ELI LILLY AND COMPANY (US) 1998-03-10 — — US claimed
EP-0672658-A1 Antithrombotic agents ELI LILLY AND COMPANY (US) 1995-09-20 — — EP claimed
WO-1995023609-A1 ANTITHROMBOTIC AGENTS ELI LILLY AND COMPANY (US) 1995-09-08 — — WO claimed
EP-1361212-A1 Peptide derivatives as antithrombotic agents AstraZeneca AB (SE) 2003-11-12 — — EP disclosed
US-5726159-A PEPTIDE THROMBIN INHIBITORS ELI LILLY AND COMPANY (US) 1998-03-10 — — US disclosed
EP-0672658-A1 Antithrombotic agents ELI LILLY AND COMPANY (US) 1995-09-20 — — EP disclosed
WO-1995023609-A1 ANTITHROMBOTIC AGENTS ELI LILLY AND COMPANY (US) 1995-09-08 — — WO disclosed
Send feedback